The advancement and innovation of new healthcare technologies are developing the platform for the growth of precision medicine market. Since, the announcement of ‘Precision Medicine Initiative’ by the President Barack Obama in January, 2015, a large number of research and development has been taken for the development of precise drugs, targeted therapeutics, and laboratory tests. Presently, the main focus of the government initiatives is toward oncology, but it is anticipated to target almost all therapeutic areas affected by genetic mutations.
Governmental regulations and standards are sustaining the growth and development of the precision medicine market. The main aim of these regulations is to make precision medicines more adaptable and focused towards genetic diseases related to Oncology, skin, respiratory, CNS, CVD, and infectious diseases among others. The patients are benefitted indirectly by these regulations as it save time and cut-down cost as the patients get the required treatment for the specific disease.
The growth in the precision medicine market is propelled by an increasing demand for personalized treatment, technological innovation and advancement (including Biomarker-based tests/kits, next gene sequencing, and precise imaging), Government support and regulations, and these have created a demand for the precision medicine solutions.
Our study includes an overview and analysis of the precision medicine market by ecosystem, sub-markets, therapeutics and geographical regions, allowing the research to develop a comprehensive outlook of the market. The precision medicine market report presents detailed analysis of the entire precision medicine ecosystem and provides extensive insights of the different developments, trends and key participants. The report also focuses on different sub-markets which help in the development of precision medicine solutions. The sub-market verticals are categorized into five major categories, viz. companion diagnostics, biomarkers, targeted therapeutics, Pharmacogenomics and molecular diagnostics among others in the report.
Further, the scope of the report includes the therapeutics of different disease types managed by this technology. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC) and Rest of the World (ROW).
While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliance, and regulatory bodies and their involvement in the precision medicine market.
The answers to the following key questions can be found in the report:
What are the major market drivers, challenges and opportunities of the precision medicine market and their use cases?
What are the primary precision medicine market trends and key developments for different precision medicine systems?
What are the key developmental strategies in different applications across all regions in this market?
What are different types of precision medicine solutions and the latest precision medicine technologies?
How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launches among others?
Which geographical region will lead the global precision medicine market by the end of the forecast period?
Who are the key players in the precision medicine market?
What kind of government regulations have been implemented for different precision medicine solutions?
What are the different types of sub-markets in precision medicine market and what are the applications in which they are being used?
What is the different used case scenarios considered under different applications?
What are the different therapeutic applications in which precision medicine products are being used?
What are the precision medicine market trends and key developments in different geographical regions?
This research tries to answer various aspects of the precision medicine market such as major factors driving the market, threats that can possibly slow down the market growth, and the current growth opportunities that are going to shape the market expansion of precision medicine solutions. The research study incorporates Porter’s Five Force Model for in-depth analysis of the precision medicine market and an assessment of the factors governing it. The report builds itself upon a comprehensive value chain giving a clear understanding of ecosystem of precision medicine market penetration.
Towards the end of the report, the readers will have a clear understanding of the market dynamics, major drivers and the underlying threats and challenges that the global precision medicine industry is subjected to, including the estimation of the industry’s growth in terms of production and revenue.
The report includes the profiles of major players in the precision medicine market that allows its readers to get an insight into the industry trends. Some of the leading companies in the precision medicine market are Abbott Laboratories, Almac Group Ltd. and Caris Life sciences among others.